Overimmunization in the general population. Preliminary results;Exceso de inmunización en la población general: Resultados preliminares

Vacunas

Volumn 8, Issue 1, 2007, Pages 14-20

  Garrido, P ^a,b   Herrero, P ^a   Quilez, J ^a   Gajans, M ^a   Rosas, A ^a   Garrido, M ^c   Pallares, C ^a   Gimeno, A ^a   Manito, I ^a   Marti M ^a   Munne G ^a   Gil, A ^a   Clara J C ^a  

^a Centre d'Atenció Primaria de Montnegre   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Causes of overimmunization; Extra doses; Influenza vaccine; Overimmunization; Primary care; Tetanus; Vaccine coverage; Vaccines

Indexed keywords

INFLUENZA VACCINE; TETANUS TOXOID;

ADULT; AGED; ARTICLE; DRUG COST; FEMALE; FOLLOW UP; HUMAN; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PREVALENCE; PRIMARY MEDICAL CARE; SPAIN; TETANUS; TETANUS PROPHYLAXIS;

EID: 37849034186     PISSN: 15769887     EISSN: 15788857     Source Type: Journal    
DOI: 10.1016/S1576-9887(07)73966-3     Document Type: Article

References (43)

1. Parish HJ. A history of immunization. London: Livingstone; 1965.
2. Plotkin SA, Fantini B, editors. Vaccinia, vaccination, vaccinology: Jenner, Pasteur and their successors. Amsterdam: Elsevier; 1996.
3. Demicheli V, Barale A, Rivetti A. Vaccines for women to prevent neonatal tetanus. Cochrane Database Syst Rev. 2005;4:2959.
4. Gitta SN, Wabwire-Mangen F, Kitimbo D, Pariyo G; Centers for Disease Control and Prevention (CDC). Risk factors for neonatal tetanus-Busoga region, Uganda, 2002-2003. MMWR Morb Mortal Wkly Rep. 2006;55 Suppl 1:25-30.
5. Bytchenco B. Geographical distribution of tetanus in the world 1951-60. Bull WHO. 1966;34:71-104.
6. Standfeld JP, Galazka A. Neonatal Tetanus in the world today. Bull WHO. 1984;62:647-69.
7. US Department of Health and Human Services. Healthy people 2010 (vol 1). Washington: US Department of Health and Human Services; 2000.
8. Centers for Disease Control. Immunization registry annual report. CDC/NIP. 2000.
9. La Force MF, Nichol KL, Cox NJ. Influenza: virology, epidemiology disease and prevention. Am J Prev Med. 1994;10 Suppl:31-44.
10. Housworth J, Langmuir AD. Excess mortality from epidemic influenza 1957-1996. Am J Epidemiol. 1974;100:40-8.
11. Tillet HE, Smith JWG, Clifford RE. Excess morbidity and mortality associated with influenza in England an Wales. Lancet. 1980;1:793-5.
12. Centers for Disease Control. Surveillance of tetanus - United States, 1989-1990. MMWR. 1992;41:1-9.
13. Salleras L. Eliminación-erradicación de enfermedades infecciosas transmisibles prevenibles mediante vacunaciones. Vacunas Invest Pract. 2000;1:151-2.
14. Giangrasso J, Smith RK. Misuse of tetanus immunoprophylaxis in wound care. Ann Emerg Med. 1985;14:573-9.
15. Irigoyen MM, Findley S, Wang D, Chen S, Chimkin F, Pena O, et al. Challenges and successes of immunization registry reminders at inner-city practices. Ambul Pediatr. 2006;6:100-4.
16. Vidal J, Salleras L. Vacuna antitetánica. En: Salleras L, editor. Vacunaciones preventivas. 2.a ed. Barcelona: Masson; 2003.
17. Fornili KS, Thalheimer JC, Halperin PB, Kane DJ. The interdependence of immunization registries and community outreach programs. Am J Prev Med. 1997;13:90-6.
18. Borenstein PE, Levenson R, Watson BA, Lutz J. Potential use of immunization registries for provider education. Am J Prev Med. 1997;13:97-101.
19. Baker BJ, Appelbaum D, Hinds W, et al. CHILD profile: development of an immunization registry. Am J Prev Med. 1997;13:42-5.
20. All Kids Count of the Task Force for Child Survival and Development. The National Immunization Program of the Centers for Disease Control and Prevention. Community Immunization Registries Manual, 2000.
21. Kolasa MS, Chilkatowsky AP, Clarke KR, Lutz JP. How complete are immunization registries? The Philadelphia story. Ambul Pediatr. 2006;6:21-4.
22. Horne PR, Saarlas KN, Hinman AR. Costs of immunization registries: experiences from the All Kids Count II Projects. Am J Prev Med. 2000;19:94-8.
23. Davis RL. Vaccine Extraimmunization-Too Much of a Good Thing? JAMA. 2000;283:1339-40.
24. Feikema SM, Klevens RM, Washington ML, Barker L. Extraimmunization among US children. JAMA. 2000;283:1311-7
25. Chen RT. Vaccine risks. Vaccine. 1999;17:S41-6.
26. Middleton DB, Zimmerman RK, Mitchell KB. Vaccine schedules and procedures. J Fam Pract. 2005;54:37-50.
27. Frank JW, Schabas R, Arshinoff R, Brant R. Diphtheria-tetanus overimmunization in children with no records: can it be prevented? CMAJ. 1989;141:1241-6.
28. Sanford JP. Tetanus-Forgotten but no gone. N Engl J Med. 1995;12:812-3.
29. Bordley WC, Margolis PA, Lannon CM. The delivery of immunizations and other preventive services in private practices. Pediatrics. 1996;97:467-73.
30. Rodewald L, Peak R, Ezzati-Rice T, Zell E, Thompson K. Who are the immunization providers for U..children: findings from the 1994 National Health Interview Survey (NHIS) Provider Record Check (PRC). Ambulatory Child Health. 1997;3:168.
31. Szilagyi PG, Humiston SG, Shone LP, et al. Impact of vaccine financing on vaccinations delivered by public health clinics. Am J Public Health. 2000;90:739-45.
32. Strine TW, Barker LE, Jain RB, et al. Extraimmunization in children through 2000. JAMA. 2002;287:588-9.
33. Ronveaux O, Rickert D, Hadler S, Groom H, Lloyd J, Bchir A, et al. The immunization data quality audit: verifying the quality and consistency of immunization monitoring systems. Bull World Health Organ. 2005;83:503-10.
34. a ed. Barcelona: Generalitat de Catalunya. Departament de Salut; 2006.
35. Brayden R, France EK. Efficient vaccination practices. Pediatr Ann. 2001;30:284-8.
36. Gangarosa EJ, Galazka AM, Wolfe CR, et al. Impact of anti-vaccine movements on pertussis control: the untold story. Lancet. 1998;351:356-61.
37. Flanagan-Klygis EA, Sharp L, Frader JE. Dismissing the family who refuses vaccines: a study of pediatrician attitudes. Arch Pediatr Adolesc Med. 2005;159:929-34.
38. Smith PJ, Santoli JM, Chu SY, Ochoa DQ, Rodewald LE. The association between having a medical home and vaccination coverage among children eligible for the vaccines for children program. Pediatrics. 2005;116:130-9.
39. Barker LE, Luman ET. Changes in vaccination coverage estimates among children aged 19-35 months in the United States, 1996-1999. Am J Prev Med. 2001;20:28-31.
40. Dayan GH, Shaw KM, Baughman AL, Orellana LC, Forlenza R, Ellis A, et al. Assessment of delay in age-appropriate vaccination using survival analysis. Am J Epidemiol. 2006;163:561-70.
41. Heidary N, Cohen DE. Hypersensitivity reactions to vaccine components. Dermatitis. 2005;16:115-20.
42. Erkek E, Tuncez F, Sanli C, Duman D, Kurtipek GS, Bagci Y, et al. Nicolau's syndrome in a newborn caused by triple DTP (diphtheria-tetanus- pertussis) vaccination. Am Acad Dermatol. 2006;54:S241-2.
43. Frenkel LD, Nielsen K. Immunization issues for the 21st century. Ann Allergy Asthma Immunol. 2003;90:45-52.